EDP Sciences logo
Subscriber Authentication Point
Search
Menu
Home All issues Volume 21 / No 8-9 (Août–Septembre 2005) Med Sci (Paris), 21 8-9 (2005) 730-736 References
Free Access
Issue
Med Sci (Paris)
Volume 21, Number 8-9, Août–Septembre 2005
Page(s) 730 - 736
Section M/S revues
DOI https://doi.org/10.1051/medsci/2005218-9730
Published online 15 August 2005
  1. Fanconi G. Familiäre infantile perniziosaartige Anämie (perniziöses Blutbild und Konstitution). Jahrb Kinderheilk 1927; 117 : 257–80. [Google Scholar]
  2. Auerbach AD, Buchwald M, Jonje A. Fanconi anemia. In : Vogelstein B, Kinzler KW, eds. The genetic basis of human cancer. New York : McGraw-Hill, 1998 : 317–32. [Google Scholar]
  3. D’Andrea AD, Grompe M. The Fanconi anemia/BRCA pathway. Nat Rev Cancer 2003; 3 : 23–34. [Google Scholar]
  4. Fanconi G. Familial constitutional panmyelocytopathy, Fanconi’s anemia (FA). I. Clinical aspects. Semin Hematol 1967; 4 : 233–40. [Google Scholar]
  5. Swift M. Fanconi’s anemia in the genetics of neoplasia. Nature 1971; 230 : 370–3. [Google Scholar]
  6. Verlander PC, Kaporis A, Liu Q, et al. Carrier frequency of the IVS4+4A>T mutation of the Fanconi anemia FAC in the Ashkenasi Jewish population. Blood 1995; 86 : 4034–8. [Google Scholar]
  7. Schroeder TM, Kurt R. Spontaneous chromosome breakage and high incidence of leukemia in inherited disease. Blood 1971; 37 : 96–112. [Google Scholar]
  8. Joenje H, Patel KJ. The emerging genetic and molecular basis of Fanconi anaemia. Nature Rev Genet 2001; 2 : 446–57. [Google Scholar]
  9. Buchwald M, Moustacchi E. Is Fanconi anemia caused by a defect in the processing of DNA damage ? Mutation Res 1998; 408 : 75–90. [Google Scholar]
  10. Auerbach AD. Fanconi anemia diagnosis and the diepoxybutane (DEB) test. Exp Hematol 1993; 21 : 731–3. [Google Scholar]
  11. Auerbach AD, Allen RG. Leukemia and preleukemia in Fanconi anemia patients : a review of the literature and report of the International Fanconi Anemia Registry. Cancer Genet Cytogenet 1991; 51 : 1–15. [Google Scholar]
  12. Rosenberg PS, Greene MH, Alter BP. Cancer incidence in persons with Fanconi anemia. Blood 2003; 101 : 822–6. [Google Scholar]
  13. Gluckman E, BroxmeyerR HE, Auerbach AD, et al. Hematopoietic reconstitution in a patient with Fanconi’s anemia by means of umbilical cord blood from an HLA-identical sibling. N Engl J Med 1989; 321 : 1174–8. [Google Scholar]
  14. Gregory JJ., Wagner JE, Verlander PC, et al. Somatic mosaicism in Fanconi anemia : evidence of genotypic reversion in lymphohematopoietic stem cells. Proc Natl Acad Sci USA 2001; 98 : 2532–7. [Google Scholar]
  15. Howlett NG, Taniguchi T, Olson S, et al. Biallelic inactivation of BRCA2 in Fanconi anemia. Science 2002; 297 : 606–9. [Google Scholar]
  16. Meetei AR, de Winter JP, Medhurst AL, et al. A novel ubiquitin ligase is deficient in Fanconi anemia. Nature Genet 2003; 35 : 165–70. [Google Scholar]
  17. Meetei AR, Levitus M, Xue Y, et al. X-linked inheritance of Fanconi anemia complementation group B. Nature Genet 2004; 36 : 1219–24. [Google Scholar]
  18. Warren M, Smith A, Partridge N, et al. Structural analysis of the chicken BRCA2 gene facilitates identification of functional domains and disease causing mutations. Hum Mol Genet 2002; 11 : 841–51. [Google Scholar]
  19. Timmers C, Taniguchi T, Hejna J, et al. Positional cloning of a novel Fanconi FANCD2. Mol Cell 2001; 7 : 241–8. [Google Scholar]
  20. Garcia-Higuera I, Kuang Y, Naf D, et al. The Fanconi anemia proteins, FANCA, FANCC and FANCG/XRCC9 interact in a functional nuclear complex. Mol Cell Biol 1999; 19 : 4866–73. [Google Scholar]
  21. Pace P, Johnson M, Tan WM, et al. FANCE : the link between Fanconi anemia complex assembly and activity. EMBO J 2002; 21 : 3414–23. [Google Scholar]
  22. Levitus M, Rooimans MA, Steltenpool J, et al. Heterogeneity in Fanconi anemia : evidence for 2 new genetic subtypes. Blood 2004; 103 : 2498–2503. [Google Scholar]
  23. Garcia-Higuera I, Taniguchi T, Ganesan S, et al. Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway. Mol Cell 2001; 7 : 249–62. [Google Scholar]
  24. Medhurst AL, Huber PA, Waisfisz Q, et al. Direct interaction of the five known Fanconi anaemia proteins suggest a common functional pathway. Hum Mol Genet 2001; 10 : 423–9. [Google Scholar]
  25. Gordon SM, Buchwald M. Fanconi anemia protein complex : mapping proteins interactions in the yeast 2- and 3-hybrid systems. Blood 2003; 102 : 136–41. [Google Scholar]
  26. Thomashevski A, High AA, Drozd M, et al. The Fanconi anemia core complex forms four complexes of different sizes in different subcellular compartments. J Biol Chem 2004; 279 : 26201–9. [Google Scholar]
  27. Schimamura A, de Oca RM, Svenson JL, et al. A novel diagnostic screen for defects in the Fanconi anemia pathway. Blood 2002 ; 100; 4649–54. [Google Scholar]
  28. Soulier J, Leblanc T, Larghero J, et al., Detection of somatic mosaicism and classification of Fanconi anemia patients by analysis of the FA/BRCA pathway. Blood 2005; 105 :1329–36. [Google Scholar]
  29. Folias A, Matkovic M, Bruun D, et al. BRCA1 interacts directly with the Fanconi anemia protein FANCA. Hum MolGenet 2002; 11 : 2591–7. [Google Scholar]
  30. Hussain SE, Witt PA, Huber AL, et al. Direct interaction of the Fanconi anemia protein FANCG with BRCA2/FANCD1. Hum Mol Genet 2003; 12 : 2503–10. [Google Scholar]
  31. Wang XZ, Andreassen PR, d’Andrea AD. Functional interaction of monoubiquitinated FANCD2 and BRCA2/FANCD1 in chromatin. Mol Cell Biol 2004; 24 : 5850–62. [Google Scholar]
  32. Nijman SMB, Huang TT, Dirac AMG, et al. The deuibiquitinating enzyme USP1 regulates the Fanconi anemia pathway. Mol Cell 2005; 17 : 331–9. [Google Scholar]
  33. Taniguchi T, Garcia-Higuera I, Xu B, et al. Convergence of the Fanconi anemia and ataxia telangiectasia signaling pathways. Cell 2002; 109 : 459–72. [Google Scholar]
  34. Nakanishi K, Taniguchi T, Ranganathan V, et al. Interaction of FANCD2 and NBS1 in the DNA damage response. Nat Cell Biol 2002; 4 : 913–20. [Google Scholar]
  35. Pichierri P, Rosselli F. The DNA crosslink-induced S-phase checkpoint depends on ATR-CHK1 and ATR-NBS1-FANCD2 pathways. EMBO J 2004; 23 : 1178–87. [Google Scholar]
  36. Andreassen PR, D’Andrea A, Taniguchi T. ATR couples FANCD2 monoubiquitination to the DNA-damage response. Genes Dev 2004; 18 : 1958–63. [Google Scholar]
  37. Shiloh Y. ATM and related protein kinases : safeguarding genome integrity. Nat Rev Cancer 2003; 3 : 155–8. [Google Scholar]
  38. D’Amours D, Jackson SP. The Mre11 complex : at the crossroads of DNA repair and checkpoint signaling. Nat Rev Mol Cell Biol 2002; 5 : 317–27. [Google Scholar]
  39. FujiwaraY, Tatsumi M. Cross-link repair in human cells and its possible defect in Fanconi’s anemia cells. J Mol Biol 1977; 113 : 635–49. [Google Scholar]
  40. Papadopoulo D, Averbeck D, Moustacchi E. The fate of 8-methoxypsoralen photoinduced DNA interstrand cross-links in Fanconi’s anemia cells of defined genetic complementation groups. Mutat Res 1987; 184 : 271–80. [Google Scholar]
  41. Rousset S, Nocentini S, Revet B, Moustacchi E. Molecular analysis by electron microscopy of the removal of psoralen-photoinduced DNA cross-links in normal and Fanconi’s anemia fibroblasts. Cancer Res 1990; 50 : 2443–8. [Google Scholar]
  42. Papadopoulo D, Guillouf C, Mohrenweiser H, Moustacchi E. Hypomutability in Fanconi anemia cells is associated with increased deletion frequency at the HPRT locus. Proc Natl Acad Sci USA 1990; 87 : 8383–7. [Google Scholar]
  43. Lambert MW, Tsongalis GJ, Lambert WC, et al. Defective DNA endonuclease activities in Fanconi’s anemia cells, complementation groups A and B. Mutat Res 1992; 273 : 57–71. [Google Scholar]
  44. Escarceller M, Buchwald M, Singleton BK, et al. Fanconi anemia C gene product plays a role in the fidelity of blunt DNA end-joining. J Mol Biol 1998; 279 : 375–85. [Google Scholar]
  45. Lundberg R, Mavinakere M, Campbell C. Deficient DNA end joining activity in extracts from Fanconi anemia fibroblasts. J Biol Chem 2001; 276 : 9543–9. [Google Scholar]
  46. Centurion SA, Kuo HR, Lambert WC. Damage-resistant DNA synthesis in Fanconi anemia cells treated with a DNA cross-linking agent. Exp Cell Res 2000; 260 ; 216–21. [Google Scholar]
  47. Sala-Trepat M, Rouillard D, Escarceller M, et al. The arrest of S-phase progression is impaired in Fanconi anemia cells. Exp Cell Res 2000; 260 : 208–15. [Google Scholar]
  48. Dutrillaux B, Aurias A, Dutrillaux AM, et al. The cell cycle of lymphocytes in Fanconi anemia. Hum Genet 1992; 62 : 327–32. [Google Scholar]
  49. Hursh B, Shimamura A, Moreau L, et al. Association of biallelic BRCA2/FANCD1 mutations with spontaneous chromosomal instability and solid tumors of childhood. Blood 2004; 103 : 2554 –9. [Google Scholar]
  50. Tischkowitz MD, Morgan NV, Grimwade D, et al. Deletion and reduced expression of the Fanconi anemia FANCA gene in sporadic acute myeloid leukemia. Leukemia 2004; 18 : 420–5. [Google Scholar]
  51. Narayan G, Arias-Pulido H, Nandula SV, et al. Promoter hypermethylation of FANCF : disruption of Fanconi anemia-BRCA pathway in cervical cancer. Cancer Res 2004; 64 : 2994–7. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.